PA produces motility alterations and decreased phosphorylation of p44/42 MAPK in podocytes. by Cristina Martínez-García (823460)

Decreasing neural activity in MBONs that suppress PER when activated has modest effects. by Justine Chia (5459294)

ADAM17 silencing increases adhesion and decreases migration of lymphatic endothelial cells (LEC). by Renata Mężyk-Kopeć (112354)

Increased inflammation and decreased proliferation in DSS-treated<i>Mttp-IKO</i> mice. by Yan Xie (41714)

Nepmucin/CD300LG expression is decreased in tumors and tumor-draining lymph nodes. by Eiji Umemoto (1637)

Simvastatin decreases cerebral vasospasm of the middle cerebral artery and reduces microthromboemboli after SAH. by Mohammed Sabri (355717)

“…Representative images from immunohistochemical staining of fibrinogen show the presence of numerous microthromboembli in SAH animals treated with vehicle (arrow heads) but only few in animals treated with simvastatin either pre- or post-SAH, and none in the naïve controls. Scale bar is 100 µm. <b>D</b> and <b>E</b>. Both pre-SAH and post-SAH treatment with simvastatin significantly decrease microthromboemboli in both cerebral cortex (<i>P</i><0.001) and hippocampus (<i>P</i><0.01) as compared to vehicle treated group. …”

Exposure to low CO₂ levels decreases ER cholesterol levels. by Nityanand Bolshette (17396845)

“…<b>(B)</b> Bioluminescence recordings from the different conditions as depicted in <b>(A)</b>, the arrow indicates the time CO₂ was shifted from 5% to 1% (mean ± SE, <i>n</i> = 4 biological replicates per condition, AUC for 0 mM 0.34 ± 0.007, 1.59 ± 0.004 (<i>P</i> < 0.0001), 0.5 mM 1.00 ± 0.023, 2.68 ± 0.04 (<i>P</i> < 0.0001), 1 mM 1.66 ± 0.07, 3.34 ± 0.04 (<i>P</i> < 0.0001), 3 mM 2.06 ± 0.02, 2.79 ± 0.07 (<i>P</i> < 0.0001), 5 mM 2.02 ± 0.05, 2.43 ± 0.06 (<i>P</i> < 0.002), 7 mM 1.85 ± 0.01, 1.77 ± 0.02 (<i>P</i> < 0.02) two-sided Student’s <i>t</i> test). …”

mir-93 inhibits tumor growth and metastasis by decreasing CSCs in SUM159 cells. by Suling Liu (9555)

Hsp90 inhibition decreases the adipogenic transcriptional program without any effect on cytotoxicity. by Sébastien Desarzens (547289)

Puriton had the tendency of decreasing expressions of Th1 cell-related cytokines such as IFN- by So-Hyeon Bok (8066696)

siRNA-mediated knock-down significantly decreases MLL fusion expression levels. by Marieke H. van der Linden (706995)

Serotonin deficiency decreases calcium transporters expression in the mammary gland on d 10 of lactation. by Jimena Laporta (383836)

RhoGTPase inhibition using dominat negative gene products decreases transgene expression. by Anandika Dhaliwal (171763)

GBE did not modify cell morphology but decreased reactive oxygen species (ROS) levels. by Virginie Rhein (243241)

“…<b>D</b>) ROS levels (DHR fluorescence units/1×10⁵ cells normalized to the respective untreated control and APP cells = 100%) were significantly decreased after treatment with GBE (100 µg/ml; 24 h). …”

Retinoic acid improved cell morphology and decreased the number of hypertrophic cells in LT cultures. by Carmen Retana (479628)

“…<p>(<b>A</b>) Omentum-derived mesothelial cells (control) and effluent-derived mesothelial cells from LT and HT grown until confluence in the presence of ATRA (0, 50, 100 and 200 nM). …”

<i>Cadm1</i> KO mice exhibit decreased bone mineral density. by Shinya Nakamura (97647)

Casein kinase 1.2 depletion decreases ZC3H11 phosphorylation. by Igor Minia (399074)

“…</b> CK1.2 depletion causes a decrease in phosphorylated ZC3H11. RNAi was induced for 2 days, then the cells were transferred to either 37°C or 41°C for 1 hour. …”

Knockdown of CoREST1 decreased tumor cell-mediated macrophage migration and activation. by Sohini Mazumdar (707540)

Down-regulation of <i>T. gondii</i> P-gp correlates with decreased lipid synthesis. by Iveta Bottova (250537)

Troglitazone decreases α5 integrin-dependent cell adhesion in K562 cells. by Amanda M. Hanson (543116)